No disclosed counterparties: EVI, SCI.
| Stage | EVI | % of rev | SCI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $122M | 100.00% | $1.1B | 100.00% | SCI ×9.09 |
| Gross profit | $38M | 31.57% | $272M | 24.59% | EVI +7.0pp |
| Operating income | $6M | 4.63% | $253M | 22.84% | SCI +18.2pp |
| Pre-tax income | $5M | 3.83% | $189M | 17.05% | SCI +13.2pp |
| Net income | $3M | 2.25% | $141M | 12.76% | SCI +10.5pp |
| Stage | EVI | SCI | Gap · A − B |
|---|---|---|---|
| Revenue | $122M100.00% | $1.1B100.00% | SCI ×9.09 |
| Gross profit | 31.57%$38M | 24.59%$272M | EVI +7.0pp |
| Operating income | 4.63%$6M | 22.84%$253M | SCI +18.2pp |
| Pre-tax income | 3.83%$5M | 17.05%$189M | SCI +13.2pp |
| Net income | 2.25%$3M | 12.76%$141M | SCI +10.5pp |